Clinical Trials in Hirosaki, Aomori

Find clinical trials in Hirosaki, Aomori. Discover local research opportunities and treatment options in your area.

8 Active Trials Found in Hirosaki

Showing 8 trials on this page

Page 1 of 1

Pan Tumor Rollover Study

NCT ID: NCT03899155

The Pan Tumor Rollover Study is a clinical trial focused on understanding the long-term safety of a cancer treatment called nivolumab, both on its own and in combination with other therapies. This ...

Recruiting

Phase: PHASE2 Conditions: Cancer

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

NCT ID: NCT06598943

This clinical trial is looking at two medications, eltrekibart and mirikizumab, to see how safe and effective they are for adults with moderately to severely active ulcerative colitis (UC). Ulcerat...

Recruiting

Phase: PHASE2 Conditions: Ulcerative Colitis, Ulcerative Colitis Chronic

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

NCT ID: NCT06170788

This clinical trial is studying a new treatment approach for patients with metastatic non-small cell lung cancer (NSCLC), specifically those whose tumors have a high level of a protein called PD-L1...

Recruiting

Phase: PHASE3 Conditions: Non-small Cell Lung Cancer (NSCLC)

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

NCT ID: NCT06422143

This clinical trial is exploring a new treatment approach for patients with metastatic squamous non-small cell lung cancer (NSCLC). The study is testing whether adding a drug called sacituzumab tir...

Recruiting

Phase: PHASE3 Conditions: Non-small Cell Lung Cancer, NSCLC

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

NCT ID: NCT03519945

The LUCENT 3 clinical trial is studying a medication called mirikizumab to see how effective and safe it is for treating people with moderately to severely active ulcerative colitis (UC) over a lon...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

NCT ID: NCT06632951

This clinical trial is studying a new treatment combination for adults with urothelial carcinoma (UC), a type of cancer that affects the bladder and other parts of the urinary system. Researchers w...

Recruiting

Phase: PHASE2 Conditions: Urothelial Carcinoma

A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

NCT ID: NCT04738942

This clinical trial is studying a medication called vedolizumab, which is given through an IV (intravenous) drip, to see if it helps improve symptoms in Japanese patients with moderate to severe ul...

Recruiting

Phase: PHASE3 Conditions: Ulcerative Colitis, Crohn's Disease

Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

NCT ID: NCT05392764

The EMPA-AHF trial is a clinical study investigating the effects of a medication called empagliflozin on patients who are hospitalized for acute heart failure (AHF) and are at high risk for serious...

Recruiting

Phase: PHASE3 Conditions: Acute Heart Failure

Search All Trials Browse All Locations